Colin Guy, PhD

Dr. Colin Guy received his PhD (biochemistry) from the University of Nottingham in 2006, and following postdoctoral studies, he joined Labcorp Drug Development in 2010. He has a broad range of experience within the biochemistry field, including in liquid chromatography, capillary and gel electrophoresis and ligand binding assays.

As a senior manager within the GMP Research and Development team at Labcorp Biopharmaceutical CMC Services, he is responsible for the scientific oversight of analytical development for a range of modalities including monoclonal antibodies, vaccines, and cell and gene therapy. Within this role, Colin provides scientific leadership and technical guidance for our clients to ensure appropriate methods are employed to monitor the CQAs of therapeutics throughout the product life cycle.